Protect IP To Encourage Switching In Australia, Urges ASMI
Executive Summary
The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia.
You may also be interested in...
Triptan Switches Offer Hope For Australia’s OTC Market
Switch expert Natalie Gauld says recent triptan switch recommendations signal a turnaround for Australia's OTC market.
German Industry Wants To Simplify 'Complicated' Switch Process
The German Medicines Manufacturers´ Association
Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy
The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.